Elsevier

Respiratory Medicine

Volume 97, Issue 4, April 2003, Pages 295-301
Respiratory Medicine

Review
Twenty-first century tobacco use: it is not just a risk factor anymore

https://doi.org/10.1053/rmed.2002.1443Get rights and content
Under an Elsevier user license
open archive

Abstract

Despite availability of effective treatments for nicotine addiction, smoking remains prevalent with serious health consequences. Most smokers recognize the ill effects of smoking but are unable to quit. Nicotine addiction may be viewed as any other chronic illness that results from exposure to a recognizable agent (tobacco) and manifests with a well-documented set of signs and symptoms. Much like any chronic disease, both environmental and genetic factors determine the occurrence and severity of this affliction. There has been recent focus on uncovering the genetic basis of nicotine addiction. In this article, we have attempted to briefly review the current evidence for the role of genetics in smoking as well as comment on available pharmacotherapeutic options for treating nicotine dependence.

Keywords

smoking cessation
tobacco
nicotine replacement therapy
genetics
Bupropion.

Cited by (0)

f1

Correspondence should be addressed to: Frank T. Leone, MD, MS, Comprehensive Center for Tobacco Research & Training, Jefferson Medical College, 1025 Walnut Street, 805 College Building, Philadelphia, PA 19107, U.S.A. Fax: +1 215 9550830;

E-mail: [email protected]